Ticktin Robert 4
4 · PMV Pharmaceuticals, Inc. · Filed Jul 3, 2025
Insider Transaction Report
Form 4
Ticktin Robert
General Counsel & COO
Transactions
- Sale
Common Stock
2025-07-01$1.06/sh−23,151$24,651→ 98,695 total
Footnotes (2)
- [F1]The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.
- [F2]Includes 15,528 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025.